Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg M N Behrens

Showing results (1-10 of 141) with videos related to

Pageof 15
Sort By:
The New England Journal of Medicine|April 22, 2005
Cardiovascular risk and body-fat abnormalities in HIV-infected adultsGeorg M N Behrens
Open Forum Infectious Diseases|October 25, 2021
Beyond Viral SuppressionGeorg M N Behrens
Herz|September 20, 2005
[Metabolic syndrome and hyperlipidemia in HIV-positive patients]Georg M N Behrens
AIDS (London, England)|October 15, 2011
Abacavir and myocardial infarctions: the benefit of doubt?Georg M N Behrens
Current Opinion in Infectious Diseases|December 10, 2009
Abacavir and cardiovascular riskGeorg M N Behrens, Peter Reiss
Current Pharmaceutical Design|August 7, 2010
Contribution of inflammation to fat redistribution and metabolic disturbances in HIV-1 infected patientsMetodi V Stankov, Georg M N Behrens
AIDS (London, England)|April 8, 2021
Hypophosphatemia in people with HIV: no benefit when switching from tenofovir disoproxil fumarate to tenfovir alafenamideLisa Sandmann, Matthias Stoll, Georg M N Behrens
Advances in Cardiology|October 10, 2003
Pathogenesis of the HAART-associated metabolic syndromeGeorg M N Behrens, Matthias Stoll, Reinhold E Schmidt
Journal of Acquired Immune Deficiency Syndromes (1999)|December 13, 2021
Close to Zero, but Not Zero: What Is an Acceptable HIV Transmission Risk Through Breastfeeding?Georg M N Behrens, Karoline Aebi-Popp, Abdel Babiker
Antimicrobial Agents and Chemotherapy|May 14, 2008
Zidovudine impairs adipogenic differentiation through inhibition of clonal expansionMetodi V Stankov, Reinhold E Schmidt, Georg M N Behrens, et al.
Pageof 15

Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
The New England Journal of Medicine|April 22, 2005
Cardiovascular risk and body-fat abnormalities in HIV-infected adultsGeorg M N Behrens
Open Forum Infectious Diseases|October 25, 2021
Beyond Viral SuppressionGeorg M N Behrens
Herz|September 20, 2005
[Metabolic syndrome and hyperlipidemia in HIV-positive patients]Georg M N Behrens
AIDS (London, England)|October 15, 2011
Abacavir and myocardial infarctions: the benefit of doubt?Georg M N Behrens
Current Opinion in Infectious Diseases|December 10, 2009
Abacavir and cardiovascular riskGeorg M N Behrens, Peter Reiss
Current Pharmaceutical Design|August 7, 2010
Contribution of inflammation to fat redistribution and metabolic disturbances in HIV-1 infected patientsMetodi V Stankov, Georg M N Behrens
AIDS (London, England)|April 8, 2021
Hypophosphatemia in people with HIV: no benefit when switching from tenofovir disoproxil fumarate to tenfovir alafenamideLisa Sandmann, Matthias Stoll, Georg M N Behrens
Advances in Cardiology|October 10, 2003
Pathogenesis of the HAART-associated metabolic syndromeGeorg M N Behrens, Matthias Stoll, Reinhold E Schmidt
Journal of Acquired Immune Deficiency Syndromes (1999)|December 13, 2021
Close to Zero, but Not Zero: What Is an Acceptable HIV Transmission Risk Through Breastfeeding?Georg M N Behrens, Karoline Aebi-Popp, Abdel Babiker
Antimicrobial Agents and Chemotherapy|May 14, 2008
Zidovudine impairs adipogenic differentiation through inhibition of clonal expansionMetodi V Stankov, Reinhold E Schmidt, Georg M N Behrens, et al.
Pageof 15